N-(4-(1-((2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)-3-BUTYN-1-YL)BENZOYL)-L-GLUTAMIC ACID

UNII:	H6BX8CT63H
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₃H₂₂N₆O₆
Preferred Substance Name:	N-(4-(1-((2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)-3-BUTYN-1-YL)BENZOYL)-L-GLUTAMIC ACID
InChIKey:	XIENBUCQFATNPH-WMCAAGNKSA-N
GSRS Full Record:	H6BX8CT63H i

1548618-61-6
(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic Acid
L-Glutamic acid, N-[4-[1-[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-
N-[4-[1-[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-L-glutamic acid
Pralatrexate Impurity 3

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

N-(4-(1-((2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL)-3-BUTYN-1-YL)BENZOYL)-L-GLUTAMIC ACID

Synonyms and Mappings

Resources